Professional type I interferon-producing cells - A unique subpopulation of dendritic cells

Acta Microbiologica et Immunologica Hungarica

Volumn 52, Issue 3-4, 2005, Pages 443-462

  Magyarics, Z ^a   Rajnavölgyi, Éva ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Dendritic cells; Interferons; Regulation of immune responses

Indexed keywords

EID: 29144524877     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.52.2005.3-4.14     Document Type: Article

References (75)

1. Mogensen, K. E., Lewerenz, M., Reboul, J., Lutfalla, G., Uze, G.: The type I interferon receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 19, 1069-1098 (1999).
2. Lennert, K., Remmele, W.: Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes.]. Acta Haematol 19, 99-113 (1958).
3. Facchetti, F., Vermi, W., Mason, D., Colonna, M.: The plasmacytoid monocyte/interferon producing cells. Virchows Arch 443, 703-717 (2003).
4. Liu, Y. J.: IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol (2004).
5. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., Liu, Y. J.: The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
6. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., Colonna, M.: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 5, 919-923 (1999).
7. Barnes, B. J., Richards, J., Mancl, M., Hanash, S., Beretta, L., Pitha, P. M.: Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279, 45194-45207 (2004).
8. Levy, D. E., Kessler, D. S., Pine, R., Darnell, J. E., Jr.: Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev 3, 1362-1371 (1989).
9. Kessler, D. S., Veals, S. A., Fu, X. Y., Levy, D. E.: Interferon-alpha regulates nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 4, 1753-1765 (1990).
10. Tanaka, H., Samuel, C. E.: Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc Natl Acad Sci USA 91, 7995-7999 (1994).
11. Hug, H., Costas, M., Staeheli, P., Aebi, M., Weissmann, C.: Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol Cell Biol 8, 3065-3079 (1988).
12. Cohen, B., Peretz, D., Vaiman, D., Benech, P., Chebath, J.: Enhancer-like interferon responsive sequences of the human and murine (2′-5′) oligoadenylate synthetase gene promoters. Embo J 7, 1411-1419 (1988).
13. Williams, B. R.: Signal integration via PKR. Sci STKE 2001. 2001: RE2.
14. Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., Biron, C. A.: Interferon alpha/beta-mediated inhibition and promotion of interferon gamma: STAT1 resolves a paradox. Nat Immunol 1, 70-76 (2000).
15. Shortman, K., Liu, Y. J.: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2, 151-161 (2002).
16. Olweus, J., BitMansour, A., Warnke, R., Thompson, P. A., Carballido, J., Picker, L. J., Lund-Johansen, F.: Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc Natl Acad Sci USA 94, 12551-12556 (1997).
17. Blom, B., Ho, S., Antonenko, S., Liu, Y. J.: Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192, 1785-1796 (2000).
18. Spits, H., Couwenberg, F., Bakker, A. Q., Weijer, K., Uittenbogaart, C. H.: Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med 192, 1775-1784 (2000).
19. Bendriss-Vermare, N., Barthelemy, C., Durand, I., Bruand, C., Dezutter-Dambuyant, C., Moulian, N., Berrih-Aknin, S., Caux, C., Trinchieri, G., Briere, F.: Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest 107, 835-844 (2001).
20. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., Zou, W.: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10, 942-949 (2004).
21. Krug, A., Uppaluri, R., Facchetti, F., Dorner, B. G., Sheehan, K. C., Schreiber, R. D., Cella, M., Colonna, M.: IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation. J Immunol 169, 6079-6083 (2002).
22. Penna, G., Vulcano, M., Roncari, A., Facchetti, F., Sozzani, S., Adorini, L.: Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 169, 6673-6676 (2002).
23. Schnurr, M., Toy, T., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I. D., Cebon, J., Maraskovsky, E.: Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103, 1391-1397 (2004).
24. Yokota, K., Takashima, A., Bergstresser, P. R., Arrizumi, K.: Identification of a human homologue of the dendritic cell-associated C-type lectin-1, dectin-1. Gene 272, 51-60 (2001).
25. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G.: Yamamoto, T., Zysk, M., Yamaguchi, Y., Schmitz, J., BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194, 1823-1834 (2001).
26. Salio, M., Palmowski, M. J., Atzberger, A., Hermans, I. F., Cerundolo, V.: CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med 199, 567-579 (2004).
27. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., Akira, S.: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3, 196-200 (2002).
28. Bauer, M., Redecke, V., Ellwart, J. W., Scherer, B., Kremer, J. P., Wagner, H., Lipford, G. B.: Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic; cells. J Immunol. 166, 5000-5007 (2001).
29. Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al-Shamkhani, A., Flavell, R., Borrow, P., Reis e Sousa, C.: Viral infection switches nonplasmacytoid dendritic cells into high interferon producers. Nature 424, 324-328 (2003).
30. Fonteneau, J. F., Gilliet, M., Larsson, M., Dasilva, I., Munz, C., Liu, Y. J., Bhardwaj, N.: Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 101, 3520-3526 (2003).
31. Kadowaki, N., Antonenko, S., Lau, J. Y., Liu, Y. J.: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192, 219-226 (2000).
32. Moseman, E. A., Liang, X., Dawson, A. J., Panoskaltsis-Mortari, A., Krieg, A. M., Liu, Y. J., Blazar, B. R., Chen, W.: Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 173, 4433-4442 (2004).
33. Gilliet, M., Liu, Y. J.: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195, 695-704 (2002).
34. de Heer, H. J., Hammad, H., Soullie, T., Hijdra, D., Vos, N., Willart, M. A., Hoogsteden, H. C., Lambrecht B. N.: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 200, 89-98 (2004).
35. Ito, T., Amakawa, R., Kaisho, T., Hemmi, H., Tajima, K., Uehira, K., Ozaki, Y., Tomizawa, H., Akira, S., Fukuhara, S.: Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 195, 1507-1512 (2002).
36. Beignon, A. S., Skoberne, M., Bhardwaj, N.: Type I interferons promote cross-priming: more functions for old cytokines. Nat Immunol 4, 939-941 (2003).
37. Rissoan, M. C., Duhen, T., Bridon, J. M., Bendriss-Vermare, N., Peronne, C., de Saint Vis, B., Briere, F., Bates, E. E.: Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 100, 3295-3303 (2002).
38. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R., Uze, G.: Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur J Immunol 34, 796-805 (2004).
39. Smith, E. J., Marie, I., Prakash, A., Garcia-Sastre, A., Levy, D. E.: IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein. J Biol Chem 276, 8951-8957 (2001).
40. Mogensen, T. H., Paludan, S. R.: Reading the viral signature by Toll-like receptors and other pattern recognition receptors. J Mol Med 83, 180-192 (2005).
41. Heim, M. H.: RIG-I: an essential regulator of virus-induced interferon production. J Hepatol 42, 431-433 (2005).
42. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J., Uematsu, S., Takeuchi, O., Akira, S.: Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061-1068 (2004).
43. Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., Fujita, T.: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730-737 (2004).
44. Goodbourn, S., Didcock, L., Randall, R. E.: Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81, 2341-2364 (2000).
45. Ito, T., Amakawa, R., Inaba, M., Ikehara, S., Inaba, K., Fukuhara, S.: Differential regulation of human blood dendritic cell subsets by IFNs. J Immunol 166, 2961-2969 (2001).
46. Li, K., Chen, Z., Kato, N., Gale, M., Jr., Lemon, S. M.: Distinct poly-I: C and virus-activated signaling pathways leading to interferon-β production in hepatocytes. J Biol Chem 280, 16739-16747 (2005).
47. Tagliaferri, P., Caraglia, M., Budillon, A., Marra, M., Vitale, G., Viscomi, C., Masciari, S., Tassone, P., Abbruzzese, A., Venuta, S.: New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-alpha) treatment of human cancer. Cancer Immunol Immunother 54, 1-10 (2005).
48. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G.: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168, 4531-4537 (2002).
49. Miettinen, M., Sareneva, T., Julkunen, I., Matikainen, S.: IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2, 349-355 (2001).
50. Fonteneau, J. F., Larsson, M., Beignon, A. S., McKenna, K., Dasilva, I., Amara, A., Liu, Y. J., Lifson, J. D., Littman, D. R., Bhardwaj, N.: Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J Virol 78, 5223-5232 (2004).
51. Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., Tough, D. F.: Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4, 1009-1015 (2003).
52. Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Van Uden, J. H., Horner, A., Corr, M., Raz, E.: IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 168, 4907-4913 (2002).
53. Sevilla, N., McGavern, D. B., Teng, C., Kunz, S., Oldstone, M. B.: Viral targeting of hematopoietic progenitors and inhibition of DC maturation as a dual strategy for immune subversion. J Clin Invest 113, 737-745 (2004).
54. Matsuda, H., Suda, T., Hashizume, H., Yokomura, K., Asada, K., Suzuki, K., Chida, K., Nakamura, H.: Alteration of balance between myeloid dendritic cells and plasmacytoid dendritic cells in peripheral blood of patients with asthma. Am J Respir Crit Care Med 166, 1050-1054 (2002).
55. Barron, M. A., Blyveis, N., Palmer, B. E., MaWhinney, S., Wilson, C. C.: Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 187, 26-37 (2003).
56. Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., Berenzi, A., Cella, M., Colonna, M.: Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 200, 255-268 (2003).
57. Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., Luster, A. D.: Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 115, 407-417 (2005).
58. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., Pascual, V.: Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197, 711-723 (2003).
59. Pileri, S., Kikuchi, M., Helbron, D., Lennert, K.: Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol 395, 257-271 1982.
60. Harris, N. L., Demirjian, Z.: Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization. Am J Surg Pathol 15, 87-95 (1991).
61. Salio, M., Cella, M., Vermi, W., Facchetti, F., Palmowski, M. J., Smith, C. L., Shepherd, D., Colonna, M., Cerundolo, V.: Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions. Eur J Immunol 33, 1052-1062 (2003).
62. Hartmann, E., Wollenberg, B., Rothenfusser, S., Wagner, M., Wellisch, D., Mack, B., Giese, T., Gires, O., Endres, S., Hartmann, G.: Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 63, 6478-6487 (2003).
63. Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., Pustilnik, T., Curiel, D. T., Galanaud, P., Capron, F., Emilie, D., Curiel, T. J.: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7, 1339-1346 (2001).
64. Horny, H. P., Feller, A. C., Horst, H. A., Lennert, K.: Immunocytology of plasmacytoid T cells: marker analysis indicates a unique phenotype of this enigmatic cell. Hum Pathol 18, 28-32 (1987).
65. Jacob, M. C., Chaperot, L., Mossuz, P., Feuillard, J., Valensi, F., Leroux, D., Bene, M. C., Bensa, J. C., Briere, F., Plumas, J.: CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica 88, 941-955 (2003).
66. Comeau, M. R., Van der Vuurst de Vries, A. R., Maliszewski, C. R., Galibert, L.: CD123 bright plasmacytoid predendritic cells: progenitors undergoing cell fate conversion? J Immunol 169, 75-83 (2002.).
67. Borden, E. C.: Gene regulation and clinical roles for interferons in neoplastic diseases. Oncologist 3, 198-203 (1998).
68. Belardelli, F., Ferrantini, M., Proietti, E., Kirkwood, J. M.: Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13, 119-134 (2002).
69. Talpaz, M., McCredie, K. B., Mavligit, G. M., Gutterman, J. U.: Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia. Blood 62, 689-692 (1983).
70. Silver, R. T., Woolf, S. H., Hehlmann, R., Appelbaum, F. R., Anderson, J., Bennett, C., Goldman, J. M., Guilhot, F., Kantarjian, H. M., Lichtin, A. E., Talpaz, M., Tura, S.: An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology. Blood 94, 1517-1536 (1999).
71. Ozer, H., George, S. L., Schiffer, C. A., Rao, K., Rao, P. N., Wurster-Hill, D. H., Arthur, D. D., Powell, B., Gottlieb, A., Peterson, B. A. et al.: Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood 82, 2975-2984 (1993).
72. Paquette, R. L., Hsu, N., Said, J., Mohammed, M., Rao, N. P., Shih, G., Schiller, G., Sawyers, C., Glaspy, J. A.: Interferon-alpha induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo. Leukemia 16, 1484-1489 (2002).
73. Yasukawa, M., Ohminami, H., Kojima, K., Hato, T., Hasegawa, A., Takahashi, T., Hirai, H., Fujita, S.: HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes. Blood 98, 1498-1505 (2001).
74. Druker, B. J., Sawyers, C. L., Capdeville, R., Ford, J. M., Baccarani, M., Goldman, J. M.: Chronic myelogenous leukemia. Hematology (Am Soc Hematol Educ Program) 87-112 (2001).
75. Balint, E., Bakay, M., Onody, K., Farkas, F., Horvath, G., Tolvaj, G., David, K., Horanyi, M., Beladi, I.: Therapy-induced antibodies against the antiviral and antiproliferative effects of interferons in patients with chronic hepatitis C virus infection. Acta Microbiol Immunol Hung 51, 359-369 (2004).